In human and mouse glioblastomas, B cells are characterized by predominantly immunosuppressive activity due to overexpression of the inhibitory molecules PD-L1 and CD155 and the immunosuppressive cytokines TGF-ß and Il-10, which are known to inhibit the effector function of T cells [32,33]. The gene discussed is CD274; the disease is glioblastoma.